GlassScriptPhysician profile
Justin Stufflebeam
NPI 1215468608
$395.84
in general payments reported to CMS, 2019-2025
8 companies · $234 in 2025
The $234 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $129 · 2024: $32.52 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $395.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $150.53 | 2025 | Titan Sgs Bailout Chuck |
| Davol INC. | $128.92 | 2023 | Phasix Mesh |
| Solventum Corporation | $29.98 | 2024-2025 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
| Becton, Dickinson and Company | $18.80 | 2024 | Phasix Mesh |
| Organogenesis INC. | $18.33 | 2025 | Puraply Wound Matrix |
| Pacira Pharmaceuticals Incorporated | $17.41 | 2025 | Exparel |
| Ethicon US, LLC | $17.22 | 2025 | Surgicel Nu-Knit, Stratafix, Vistaseal |
| Smith+Nephew, INC. | $14.65 | 2025 | Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Stufflebeam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.